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TERMINOLOGY 
To the Editor: 
In my recent review entitled "Lymphocyte Traffic, T Cell Malignan-
cies in Skin," (J In ues Derma.tol 71:167-178 1978), I inappropriately 
credited Steinmuller with coining the term "passenger leucocytes." In 
point of fact, while the concept inherent in passenger leucocytes was 
clearly stated fU'st by Steinmuller in 1967, the term "passenger leuco-
cytes" was fU'st used by Drs. Elkins and Guttmann in 1968 (Science, 
Vol. 159, Pages 1250-1251) . 
J. Wayne Streilein 
Professor of Cell Biology 
and In ternal Medicine 
PROLIFERATION OF PSORIATIC CELLS IN VITRO 
In this article Drs. Harper, Rispler, and Urbanek (JID 70:254, 1978) 
using explant cultures of human skin state that their data clearly 
indica te increased epidermal proliferation by psoria tic cells in vitro . 
Their evidence for this is the difference in the labeling index of skin 
explants from normal patients versus explants from psoriatic patients 
(either involved or uninvolved). The normal labeling index was 8% 
whereas the psoria tic was 23%. Also when they carried out a 72 hr 
labeling to estimate the total number of cells in the proliferative 
population there were 43% of the cells in the proliferative population in 
the normal and 71% in the psoriatic. 
If one corrects the labeling indices for t he proportion of cells in the 
proliferative population one can obtain the number of cells in "S" in 
those cells which are proliferating. That is a normal labeling index of 
8% with only 43% of the cells in the proliferative pool, must mean that 
of t hose cells in the proliferative pool 8 x 100/43 or 19% would be in 
the'S' phase of the cell cycle at any one time, and the corrected labeling 
index would be 19%. For psoriasis the corrected labeling index would 
be 23% x 100/71 or 32%. 
S ince the total cell cycle time of the 2 cell populations has been 
fo und to be essentially the same and about 60 hr (Chopra/Flaxman, 
Cell and Tissue Kinetics, Vol 7, page 69, 1974) and the authors of the 
present paper seem to agree with this data, then one must assume that 
in the normal if 19% of cells are in 'S' at anyone t ime and the ce ll cycle 
is 60 hI' long then 'S' must be 12 hr in duration, since'S' is approximately 
20% of the total ce ll cycle. Similarly in psoriatic tissue where 32% of the 
cells were in 'S' a t anyone t ime out of the total of 60 hr the'S ' must be 
approximate ly \1:, of the total cycle or 20 hr . Harper, Rispier, and 
Urbanek do not discuss this logical conclusion from their data which 
implies a lengthened 'S' period in psoriasis not a shortened one. 
If the tota l cell cycles are the same the differ.ence in la beling index 
would have no meaning in relation to total growth of an explant but 
certainly the increased number of cells in the proliferative pool could 
still be significant. 
In addi t ion, s ince these cultures grow with a monolayer at the 
expanding edge and an increasing number of cells piled upon one 
another going back to the original explant, how do they do their 
counting? For example, for the labeling index they counted the number 
of la beled nuclei per 1000 cells. Is that counting all nucleated cells in 
the explant? Only those in monolayer? How do they ta ke into account 
tri t iated thymidine emissions going through a varying number of over-
lying ce lls on its way to hi tting the a udioradiographic frlm '? 
Kenneth M. Halprin, M.D. 
Ha ns Hammer, M.D. 
Miami Veterans Administration Hospital 
REPLY 
To the Editor: 
Dr. Ha lprin 's main assumption is based on the ability to integrate 
data from the paper by Chopra and Flaxman with the data reported in 
our paper. This is unwise since the protocols differ. For example, (1) 
skin specimens were obtained by different procedures (kerato'tome us 
full thickness); (2) age of cultures (8-10 days vs 7 days) ; (3) "H-
thymidine concent ration used in labeling (10 /LCi/ml vs 2 /LCi/mll and 
(4) our skin specimens were age and site matched. Therefore, we feel it 
would be invalid to extract data from the paper of Chopra and Flaxman 
and in terchange them with the data from our paper. 
If one could legitimately make a direct comparison between the 2 
papers, t he assumption of Dr. Ha lprin that the labeling index is equal 
to the time of S phase divided by the total cell cycle time (LI = T./T cl 
is invalid for our cell system. His equation is only valid for steady-state 
populations. Our cells are in exponential growth; therefore, one would 
need to know the age-distribu tion of our cells as well as T , and T G" (see 
T a ble 4.8 in Thymidine Meta.bolism and Cell Kinetics by J.E. Cleaver, 
N . Holland Publishing Co., 1967) . And finally if one does carry out the 
mathematical manipulations of Halprin, a paradox occurs. Dr. Halprin 
concludes that by substituting Chopra and Flaxman's data for T , into 
the equation LI = T./T " a longer S phase would result for the psoriatic 
ce ll than for the normal cell. This would be opposite from the data 
reported by Chopra and Flaxman. Their data clearly showed that S 
phase in psoriatic keratinocytes was significantly shorter than S phase 
in normal keratinocytes (61'2 vs 11 1'2 hr) . It is precisely because of this 
difference in S phase reported by Chopra and Flaxman in 1974 that we 
undertook a contro lled study of DNA synthesis between these 2 cells. 
The questions raised by Dr. Halprin concerning our counting tech-
niques are well taken. Since this primary cell system forms a stratified 
squamous epithelium in vitro, one must keep in mind the age of the 
cultures when carrying out various kinds of experiments. Autoradi-
ographic experiments should be carried out on cultures which have 
established a good outgrowth , but yet, are young enough for the 
majority of the outgrowth to be free from excessive piling up and 
overlapping of cells. At the time we began our experiments, 70-80% of 
each outgrowth in our cultures was free of extensive layering of cells. 
It is quite easy to focus through the layers present using a light 
microscope unt il the basal layer comes into view. We then coun t the 
number of labeled ceLIs per 1,000 nucleated cells. 
Robert A. Harper, Ph.D. 
Associate Professor of Dermatology 
T emple University 
P hiladelphia , P ennsylvania 
LANGERHANS CELLS IN VITILIGO 
To the Editor: 
A misleading statement was made in the report of the proceedings of 
the First International Workshop on Vitiligo (JID 71 , No.2, pp 165-
166, 1978). We are referring to the last sentence of paragraph 3, p 165, 
attributed to us, in which it was stated that "the number of Langerhans 
cells was increased in the depigmented skin and each cell was usually 
associated with an adjacent mononuclear cell, probably a lymphocyte." 
This statement is wrong and should read as follows: 
"The number of epidermal Langerhans ceLIs appears to be increased 
in vitiligo. Mononuclear leu kocytes have been observed by us in the 
epidermis of 2 chronically sun-exposed active lesions. However, the 
apposition of Langerhans cells and lymphocytes observed by Silberberg 
in allergic contact dermatitis has not been, to our knowledge, a char-
acte ristic finding in vitiligo." 
Gisela E. Moellmann 
Sidney N. Klaus 
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